Evelo Biosciences Inc Sustainability Reports
Evelo Biosciences, Inc. was a clinical-stage biotechnology company focused on developing orally administered medicines that act on the small intestinal axis (SINTAX) with systemic therapeutic effects.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG00H43XR78
2 reports from 2018 to 2020
Company Profile
Evelo Biosciences, Inc. was a clinical-stage biotechnology company focused on developing orally administered medicines that act on the small intestinal axis (SINTAX) with systemic therapeutic effects.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
